Eyenovia
EYEN
trading on NASDAQ
since 2018
$6.49
(Δ 116.50%)
+$3.46 since open
Eyenovia is a biopharmaceutical company specializing in innovative treatments for eye conditions, with a focus on developing topical therapies such as eye drops to reduce intraocular pressure in diseases like glaucoma.
| type | open | high | low |
market cap |
volume |
|---|---|---|---|---|---|
| stock | $3.06 | $8.21 | $3.06 | $12.45M | 29.94M |
| eps | p/e | p/s |
operating margin |
profit margin |
yield |
| -$1.59 | n/a | 965.10 | -20588.95% | -23665.31% | 0% |